Delivery Order SPE2DR25D3006-SPE2DR26FR0FC
- Not listed
- The Defense Logistics Agency awarded a $9,053.16 delivery order to AmerisourceBergen Drug Corp for 60 capsules of Ofev 150 mg, a pharmaceutical product for pulmonary fibrosis treatment. The contract employs firm fixed pricing with an ultimate completion date of January 12, 2026, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,094.99 to AmerisourceBergen Drug Corp for 60 capsules of Ofev 100 mg, a pharmaceutical product used in the treatment of pulmonary fibrosis. The contract is classified as a firm fixed price delivery order with an ultimate completion date of December 24, 2025, and was competitively awarded without any set-aside designation. Performance of this delivery order is based in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of 60 capsules of Ofev 100 mg, a pharmaceutical product used in the treatment of pulmonary fibrosis. This competitively awarded, non-set-aside delivery order carries a ceiling value of approximately $18.2K with firm fixed pricing and is scheduled for completion by January 9, 2026. The award was announced on December 17, 2025, with performance to be executed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $9,094.99 to AmerisourceBergen Drug Corp for 60-count capsules of Ofev 100 mg, a pharmaceutical product used primarily in the treatment of pulmonary fibrosis. The contract was competitively awarded on November 14, 2025, with an ultimate completion date of December 8, 2025, and involves firm fixed price pricing with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a $17,260.58 delivery order to AmerisourceBergen Drug Corp for 60 capsules of Ofev 100 mg, a pharmaceutical product used in the treatment of idiopathic pulmonary fibrosis. The contract was competitively awarded without set-aside provisions on September 24, 2025, with an ultimate completion date of October 16, 2025. This delivery order operates under a firm fixed-price arrangement and is performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $25,890.84 delivery order to AmerisourceBergen Drug Corp for 60 capsules of Ofev 100 mg, a pharmaceutical product used in the treatment of pulmonary fibrosis. This firm fixed price contract was competitively awarded without a set-aside designation and is scheduled for completion by October 14, 2025. The award was announced on September 22, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 units of Ofev 100 mg capsules, a medication used to treat idiopathic pulmonary fibrosis. This competitively awarded, non-set-aside contract was issued on October 30, 2025, with a ceiling value of $8,630.29 and an ultimate completion date of November 21, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 60 capsules of Ofev 150 mg, a pulmonary fibrosis treatment medication, with a ceiling value of $18,106.32. The award, issued on November 24, 2025, is scheduled for completion by December 16, 2025, and utilizes firm fixed-price pricing with no set-aside designation. Performance of this delivery order will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Ofev 100 mg capsules (60-count units) valued at $8,355.26 under a firm fixed-price contract. This award represents a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive pharmaceutical support vehicle that runs through December 2026. The delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ofev 100 mg capsules (60-count units) with a ceiling value of $17,260.58. This firm fixed-price delivery order, which is expected to be completed by September 2, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Ofev (nintedanib) is a medication...
- SPE2DR25D3006Indefinite Delivery Contract
- SPE2DR25D3006-SPE2DR26FR0FCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 capsules of Ofev 100 mg, a pharmaceutical product used in the treatment of pulmonary fibrosis. This is a firm fixed price delivery order with a ceiling value of $9,094.99, awarded on December 19, 2025, with an ultimate completion date of January 13, 2026. The contract contains no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. This prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support contract enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company's federal contract portfolio demonstrates its established capability as a critical pharmaceutical distributor for military and veteran healthcare systems, with extensive experience delivering brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.1k | 12/18/25 |